CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?

CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?

Abstract Calcitonin gene-related peptide (CGRP) is a neuropeptide with a pivotal role in the pathophysiology of migraine. Blockade of CGRP is a new therapeutic target for patients with migraine. CGRP and its receptors are distributed not only in the central and peripheral nervous system but also in...

Full description

Bibliographic Details
Main Authors: Valentina Favoni, Luca Giani, Linda Al-Hassany, Gian Maria Asioli, Calogera Butera, Irene de Boer, Martina Guglielmetti, Chrysoula Koniari, Theodoros Mavridis, Marge Vaikjärv, Iris Verhagen, Angela Verzina, Bart Zick, Paolo Martelletti, Simona Sacco, European Headache Federation School of Advanced Studies (EHF-SAS)
Format: Article
Language:English
Published: BMC 2019-03-01
Series:The Journal of Headache and Pain
Subjects:
CGRP
CGRP antibody
Migraine treatment
Cardiovascular
Online Access:http://link.springer.com/article/10.1186/s10194-019-0979-y

Internet

http://link.springer.com/article/10.1186/s10194-019-0979-y

Similar Items